Alison J. Ford

Publications by Year

Research Areas

Receptor Mechanisms and Signaling, Pharmacological Effects and Assays, Mast cells and histamine, Chemokine receptors and signaling, Asthma and respiratory diseases

Most-Cited Works

• → In Vitro Pharmacological Characterization of Vilanterol, a Novel Long-Acting β2-Adrenoceptor Agonist with 24-Hour Duration of Action(2012)111 cited
• → Synthesis and Structure−Activity Relationships of Long-acting β₂Adrenergic Receptor Agonists Incorporating Metabolic Inactivation: An Antedrug Approach(2010)98 cited
• → Internalization of the chemokine receptor CCR4 can be evoked by orthosteric and allosteric receptor antagonists(2014)50 cited
• → Synthesis and Structure−Activity Relationships of Long-acting β₂Adrenergic Receptor Agonists Incorporating Arylsulfonamide Groups(2009)45 cited
• → Synthesis and Structure–Activity Relationships of Indazole Arylsulfonamides as Allosteric CC-Chemokine Receptor 4 (CCR4) Antagonists(2013)43 cited
• → Discovery of a Rapidly Metabolized, Long-Acting β₂Adrenergic Receptor Agonist with a Short Onset Time Incorporating a Sulfone Group Suitable for Once-Daily Dosing(2013)23 cited
• → Lead optimisation of the N1 substituent of a novel series of indazole arylsulfonamides as CCR4 antagonists and identification of a candidate for clinical investigation(2012)20 cited
• → The discovery of long-acting saligenin β2 adrenergic receptor agonists incorporating hydantoin or uracil rings(2011)16 cited
• → Pharmacological Characterisation Of GW642444, A Long-acting ²2-agonist (LABA) With Rapid Onset And Long Duration, On Isolated Large And Small Human Airways(2010)13 cited
• → Design of Phthalazinone Amide Histamine H₁ Receptor Antagonists for Use in Rhinitis(2017)13 cited